应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GLYC GlycoMimetics Inc.
已收盘 05-09 16:00:00 EDT
0.2980
-0.0004
-0.13%
盘后
0.3025
+0.0045
+1.51%
19:22 EDT
最高
0.3180
最低
0.2980
成交量
298.90万
今开
0.3119
昨收
0.2984
日振幅
6.70%
总市值
1,921万
流通市值
1,201万
总股本
6,445万
成交额
91.27万
换手率
7.41%
流通股本
4,031万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Glycomimetics, Inc.盘中异动 股价大涨5.27%报0.322美元
自选股智能写手 · 05-08 23:02
Glycomimetics, Inc.盘中异动 股价大涨5.27%报0.322美元
GlycoMimetics Inc 预计每股亏损 16 美分 - 财报前瞻
Reuters · 05-08 02:28
GlycoMimetics Inc 预计每股亏损 16 美分 - 财报前瞻
Glycomimetics, Inc.盘中异动 股价大跌5.23%报0.299美元
自选股智能写手 · 05-07 22:04
Glycomimetics, Inc.盘中异动 股价大跌5.23%报0.299美元
美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals
Reuters · 05-07 16:20
美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals
BUZZ-血癌药物晚期研究失败,GlycoMimetics业绩下滑
Reuters · 05-06
BUZZ-血癌药物晚期研究失败,GlycoMimetics业绩下滑
Glycomimetics, Inc.盘中异动 股价大涨5.56%
自选股智能写手 · 05-02
Glycomimetics, Inc.盘中异动 股价大涨5.56%
Glycomimetics, Inc.盘中异动 大幅上涨5.18%
自选股智能写手 · 04-29
Glycomimetics, Inc.盘中异动 大幅上涨5.18%
Glycomimetics, Inc.盘中异动 早盘大幅下挫5.12%
自选股智能写手 · 04-25
Glycomimetics, Inc.盘中异动 早盘大幅下挫5.12%
Glycomimetics, Inc.盘中异动 早盘股价大涨5.58%报2.27美元
自选股智能写手 · 04-17
Glycomimetics, Inc.盘中异动 早盘股价大涨5.58%报2.27美元
Glycomimetics, Inc.盘中异动 下午盘急速跳水5.00%报2.28美元
自选股智能写手 · 04-16
Glycomimetics, Inc.盘中异动 下午盘急速跳水5.00%报2.28美元
Glycomimetics, Inc.盘中异动 临近午盘股价大跌5.14%报2.54美元
自选股智能写手 · 04-10
Glycomimetics, Inc.盘中异动 临近午盘股价大跌5.14%报2.54美元
Glycomimetics, Inc.盘中异动 下午盘股价大跌5.07%
自选股智能写手 · 04-04
Glycomimetics, Inc.盘中异动 下午盘股价大跌5.07%
Glycomimetics, Inc.2023财年实现净利润-36.90百万美元,同比增加20.97%
自选股智能写手 · 03-28
Glycomimetics, Inc.2023财年实现净利润-36.90百万美元,同比增加20.97%
Glycomimetics, Inc.盘中异动 大幅拉升5.26%报3.00美元
自选股智能写手 · 03-28
Glycomimetics, Inc.盘中异动 大幅拉升5.26%报3.00美元
加载更多
公司概况
公司名称:
GlycoMimetics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Glycomimetics, Inc.作为一家临床生物科技公司,致力于发现并开发新型拟糖物药物以解决某些疾病引起的未曾遇到的医疗需求,而碳水化合物生物技术在此类疾病中扮演关键角色。拟糖物是一簇分子,这些分子能够模仿重要生物程序中碳水化合物的结构。利用其在碳水化合物化学及碳水化合物生物领域的专业知识,公司正在开发一系列其自主所有的拟糖物,这些拟糖物能够抑制碳水化合物疾病化的功能,如在炎症反应,癌症以及传染病中的功能。公司相信这代表药物发现以治疗众多疾病的一个创新性方法。公司2003年4月4日注册成立并于2003年5月21日开始运营。公司总部设在马里兰州的盖瑟斯堡。
发行价格:
--
{"stockData":{"symbol":"GLYC","market":"US","secType":"STK","nameCN":"GlycoMimetics Inc.","latestPrice":0.298,"timestamp":1715284800000,"preClose":0.2984,"halted":0,"volume":2989029,"hourTrading":{"tag":"盘后","latestPrice":0.3025,"preClose":0.298,"latestTime":"19:22 EDT","volume":214183,"amount":64009.1722,"timestamp":1715296957299},"delay":0,"floatShares":40312961,"shares":64450385,"eps":-0.582538,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.0004,"latestTime":"05-09 16:00:00 EDT","open":0.3119,"high":0.318,"low":0.298,"amount":912748.7263226999,"amplitude":0.067024,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.582538,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715328000000},"adr":0,"listingDate":1389330000000,"adjPreClose":0.2984,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.3175,"preClose":0.2984,"latestTime":"09:28 EDT","volume":240276,"amount":75657.4220934,"timestamp":1715261316531},"postHourTrading":{"tag":"盘后","latestPrice":0.3025,"preClose":0.298,"latestTime":"19:22 EDT","volume":214183,"amount":64009.1722,"timestamp":1715296957299},"volumeRatio":0.278624},"requestUrl":"/m/hq/s/GLYC","defaultTab":"news","newsList":[{"id":"2433720783","title":"Glycomimetics, Inc.盘中异动 股价大涨5.27%报0.322美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433720783","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433720783?lang=zh_cn&edition=full","pubTime":"2024-05-08 23:02","pubTimestamp":1715180544,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日23时02分,Glycomimetics, Inc.股票出现异动,股价大幅拉升5.27%。截至发稿,该股报0.322美元/股,成交量126.254万股,换手率1.96%,振幅6.52%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。消息层面,截至23时02分,《HC Wainwright & Co.:下调GlycoMimetics评级,由买入调整至中性评级。》资讯为影响Glycomimetics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508230225861ebd1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508230225861ebd1b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433736374","title":"GlycoMimetics Inc 预计每股亏损 16 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433736374","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433736374?lang=zh_cn&edition=full","pubTime":"2024-05-08 02:28","pubTimestamp":1715106509,"startTime":"0","endTime":"0","summary":" * GlycoMimetics Inc 将于5月9日公布截至2024年3月31日的财报,预计该公司的季度收入将保持不变。* * LSEG 的分析师平均预计 GlycoMimetics Inc 每股亏损 16 美分。* 华尔街对 GlycoMimetics 公司 12 个月目标价的中位数为 0.75 美元,高于上一交易日 0.32 美元的收盘价。5月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433830397","title":"Glycomimetics, Inc.盘中异动 股价大跌5.23%报0.299美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433830397","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433830397?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:04","pubTimestamp":1715090694,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时04分,Glycomimetics, Inc.股票出现波动,股价大幅下跌5.23%。截至发稿,该股报0.299美元/股,成交量233.769万股,换手率3.63%,振幅8.62%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.72%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。消息层面,截至22时04分,《HC Wainwright & Co.:下调GlycoMimetics评级,由买入调整至中性评级。》资讯为影响Glycomimetics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722045479264c6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722045479264c6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433724078","title":"美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724078","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433724078?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:20","pubTimestamp":1715070052,"startTime":"0","endTime":"0","summary":" 路透5月7日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 ServiceNow、Ulta Beauty 和 Vertex Pharmaceuticals。要闻 * 艾睿电子 :雷蒙德-詹姆斯将目标价从130美元上调至135美元 * Cardinal Health Inc :杰富瑞将目标价从110美元下调至105美元 * ServiceNow Inc :贝雅将目标价从870美元上调至885美元 * Ulta Beauty Inc :奥本海默将目标价从500美元下调至475美元 * Vertex Pharmaceuticals Inc :Piper Sandler将目标价从450美元上调至456美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433428983","title":"BUZZ-血癌药物晚期研究失败,GlycoMimetics业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2433428983","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433428983?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:33","pubTimestamp":1714991611,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 5月6日 - ** 药物开发商GlycoMimetics 股价盘前下跌55%至82美分** 在一项晚期研究中,该公司的药物uproleselan与化疗联合使用,与单独使用化疗相比,总生存率没有达到 (link) 有统计学意义的改善。** Co公司正在对一种被称为急性髓性白血病的癌症患者进行研究,这种白血病起病于骨髓,但通常会迅速转移到血液中。 ** 接受uproleselan治疗的患者的中位总生存期为13个月,而安慰剂组为12.3个月。** 研究的主要目标是总生存期,不对移植进行普查** 截至上一交易日收盘,股价年累计下跌约 23","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432046856","title":"Glycomimetics, Inc.盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432046856","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432046856?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:41","pubTimestamp":1714657318,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时41分,Glycomimetics, Inc.股票出现波动,股价急速拉升5.56%。截至发稿,该股报1.71美元/股,成交量5.5588万股,换手率0.09%,振幅1.23%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Allarity Therapeutics, Inc.、Context Therapeutics Inc.、Aptevo Therapeutics Inc.涨幅较大,Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃,换手率分别为2075.16%、332.63%、95.11%,振幅较大的相关个股有Allarity Therapeutics, Inc.、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为65.69%、22.07%、21.42%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022141597a57ec9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022141597a57ec9a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431147860","title":"Glycomimetics, Inc.盘中异动 大幅上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431147860","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431147860?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:44","pubTimestamp":1714401862,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时44分,Glycomimetics, Inc.股票出现波动,股价快速拉升5.18%。截至发稿,该股报1.73美元/股,成交量16.2168万股,换手率0.25%,振幅5.79%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。其相关个股中,Nkgen Biotech Inc C/Wts 31/05/2028、Soleno Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.涨幅较大,Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃,换手率分别为925.02%、38.45%、19.58%,振幅较大的相关个股有Annovis Bio, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ginkgo Bioworks Holdings, Inc.,振幅分别为33.93%、33.33%、31.39%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292244227924f85a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292244227924f85a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430286365","title":"Glycomimetics, Inc.盘中异动 早盘大幅下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286365","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286365?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:41","pubTimestamp":1714052470,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时41分,Glycomimetics, Inc.股票出现异动,股价快速下挫5.12%。截至发稿,该股报1.76美元/股,成交量5.2935万股,换手率0.08%,振幅2.45%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为1.37%。其相关个股中,Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大,Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃,换手率分别为1018.40%、187.63%、7.37%,振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达,振幅分别为40.85%、25.31%、14.75%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214110861e90aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214110861e90aa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428034642","title":"Glycomimetics, Inc.盘中异动 早盘股价大涨5.58%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428034642","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428034642?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:39","pubTimestamp":1713361141,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时39分,Glycomimetics, Inc.股票出现波动,股价急速拉升5.58%。截至发稿,该股报2.27美元/股,成交量1.4547万股,换手率0.02%,振幅4.19%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.涨幅较大,Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃,换手率分别为25.57%、23.60%、20.91%,振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Igc Pharma, Inc.、Lexaria Bioscience Corp.,振幅分别为26.44%、19.34%、18.61%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213901861e6b63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213901861e6b63&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427881829","title":"Glycomimetics, Inc.盘中异动 下午盘急速跳水5.00%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427881829","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427881829?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:22","pubTimestamp":1713201748,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时22分,Glycomimetics, Inc.股票出现波动,股价快速下挫5.00%。截至发稿,该股报2.28美元/股,成交量43.767万股,换手率0.68%,振幅6.46%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大,Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1499.91%、1210.56%、840.09%,振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为273.33%、114.53%、80.04%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041601222987e80829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041601222987e80829&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426238414","title":"Glycomimetics, Inc.盘中异动 临近午盘股价大跌5.14%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426238414","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426238414?lang=zh_cn&edition=full","pubTime":"2024-04-10 23:55","pubTimestamp":1712764509,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日23时55分,Glycomimetics, Inc.股票出现波动,股价大幅下跌5.14%。截至发稿,该股报2.54美元/股,成交量36.9658万股,换手率0.57%,振幅6.72%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为1.14%。其相关个股中,Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1882.91%、75.67%、44.79%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Nutriband Inc C/Wts 、Calidi Biotherapeutics, Inc.,振幅分别为87.61%、52.44%、39.88%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410235509861e4b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410235509861e4b2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424224808","title":"Glycomimetics, Inc.盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424224808","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424224808?lang=zh_cn&edition=full","pubTime":"2024-04-04 01:09","pubTimestamp":1712164185,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日01时09分,Glycomimetics, Inc.股票出现波动,股价大幅下跌5.07%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。其相关个股中,方舟生物医药、Kintara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃,换手率分别为532.36%、491.19%、76.76%,振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、珐博进,振幅分别为97.51%、58.48%、44.44%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404010945861e35bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404010945861e35bd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422134549","title":"Glycomimetics, Inc.2023财年实现净利润-36.90百万美元,同比增加20.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422134549","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422134549?lang=zh_cn&edition=full","pubTime":"2024-03-28 15:12","pubTimestamp":1711609967,"startTime":"0","endTime":"0","summary":"12月31日,Glycomimetics, Inc.公布财报,公告显示公司2023财年净利润为-36.90百万美元,同比增加20.97%;其中营业收入为10000.00美元,同比减少86.67%,每股基本收益为-0.58美元。从资产负债表来看,Glycomimetics, Inc.总负债6.90百万美元,其中短期债务741558.00美元,资产负债比为6.57,流动比率为6.41。机构评级:截至2023年12月31日,当前有3家机构对Glycomimetics, Inc.目标价做出预测,其中目标均价为7.00美元,其中最低目标价为3.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281512528b6cb273&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281512528b6cb273&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422948740","title":"Glycomimetics, Inc.盘中异动 大幅拉升5.26%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422948740","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422948740?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:32","pubTimestamp":1711557158,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时32分,Glycomimetics, Inc.股票出现波动,股价大幅拉升5.26%。截至发稿,该股报3.00美元/股,成交量13.9272万股,换手率0.22%,振幅6.32%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。其相关个股中,Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃,换手率分别为3272.27%、1212.11%、75.11%,振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.,振幅分别为86.96%、78.00%、59.87%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328003239861e1b9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328003239861e1b9f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glycomimetics.com","stockEarnings":[{"period":"1week","weight":-0.8158},{"period":"1month","weight":-0.8848},{"period":"3month","weight":-0.9068},{"period":"6month","weight":-0.7513},{"period":"1year","weight":-0.8037},{"period":"ytd","weight":-0.8736}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glycomimetics, Inc.作为一家临床生物科技公司,致力于发现并开发新型拟糖物药物以解决某些疾病引起的未曾遇到的医疗需求,而碳水化合物生物技术在此类疾病中扮演关键角色。拟糖物是一簇分子,这些分子能够模仿重要生物程序中碳水化合物的结构。利用其在碳水化合物化学及碳水化合物生物领域的专业知识,公司正在开发一系列其自主所有的拟糖物,这些拟糖物能够抑制碳水化合物疾病化的功能,如在炎症反应,癌症以及传染病中的功能。公司相信这代表药物发现以治疗众多疾病的一个创新性方法。公司2003年4月4日注册成立并于2003年5月21日开始运营。公司总部设在马里兰州的盖瑟斯堡。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.013308},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.018157},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.038199},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.08747},{"month":5,"riseRate":0.545455,"avgChangeRate":0.117153},{"month":6,"riseRate":0.3,"avgChangeRate":-0.008211},{"month":7,"riseRate":0.4,"avgChangeRate":-0.023807},{"month":8,"riseRate":0.4,"avgChangeRate":-0.061372},{"month":9,"riseRate":0.2,"avgChangeRate":-0.048353},{"month":10,"riseRate":0.4,"avgChangeRate":-0.018479},{"month":11,"riseRate":0.8,"avgChangeRate":0.344795},{"month":12,"riseRate":0.3,"avgChangeRate":0.013158}],"exchange":"NASDAQ","name":"GlycoMimetics Inc.","nameEN":"GlycoMimetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlycoMimetics Inc.(GLYC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GlycoMimetics Inc.(GLYC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GlycoMimetics Inc.,GLYC,GlycoMimetics Inc.股票,GlycoMimetics Inc.股票老虎,GlycoMimetics Inc.股票老虎国际,GlycoMimetics Inc.行情,GlycoMimetics Inc.股票行情,GlycoMimetics Inc.股价,GlycoMimetics Inc.股市,GlycoMimetics Inc.股票价格,GlycoMimetics Inc.股票交易,GlycoMimetics Inc.股票购买,GlycoMimetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlycoMimetics Inc.(GLYC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GlycoMimetics Inc.(GLYC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}